TGFB1 and cancer: SGMS2, a key regulator involved in Cer and sphingolipid homeostasis, promotes EMT mainly by increasing TGF-β1 (transforming growth factor beta 1) secretion to activate the TGF-β/Smad signaling pathway, thereby enhancing cancer cell invasiveness.66